Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure - Concepedia

Concepedia

Publication | Open Access

Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

DOI Full Paper Access

67

Citations

29

References

2019

Year

April W. Armstrong, C. Paul, L. Puig, Wolf‐Henning Boehncke, Michael L. Freeman, Hideshi Torii, Kim Papp, C.E.M. Griffiths, Andrew Blauvelt, Kristian Reich,

Dermatology and Therapy

References

	Year	Citations

Page 1